Stege, R <br/><br/>
Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jan 2000 
 - 160-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Biopsy, Needle<br/>Disease Progression<br/>Disease-Free Survival<br/>Estradiol--analogs & derivatives<br/>Estradiol Congeners--therapeutic use<br/>Follow-Up Studies<br/>Goserelin--therapeutic use<br/>Humans<br/>Lymph Node Excision<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Orchiectomy<br/>Predictive Value of Tests<br/>Prognosis<br/>Prostate-Specific Antigen--analysis<br/>Prostatic Neoplasms--blood<br/>Regression Analysis<br/>Survival Analysis<br/>Time Factors